EMT and MET: necessary or permissive for metastasis?

Molecular Oncology

Volumn 11, Issue 7, 2017, Pages 755-769

  Jolly, Mohit Kumar ^a   Ware, Kathryn E ^b   Gilja, Shivee ^b   Somarelli, Jason A ^b   Levine, Herbert ^a  

^a RICE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

epithelial to mesenchymal transition; hybrid epithelial mesenchymal; mesenchymal to epithelial transition; metastasis; phenotypic plasticity

Indexed keywords

CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PLASTICITY; CELL TRANSFORMATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IN VIVO STUDY; MESENCHYMAL TO EPITHELIAL TRANSITION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR MICROENVIRONMENT; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 85021779932     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1002/1878-0261.12083     Document Type: Review

References (153)

1. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H et al. (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110–1122.
2. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P et al. (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26, 6979–6988.
3. Amend SR, Roy S, Brown JS and Pienta KJ (2016) Ecological paradigms to understand the dynamics of metastasis. Cancer Lett 380, 237–242.
4. Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, Caserini R, Milione M, Leone G, Pelosi G et al. (2016) Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells. Mol Oncol 10, 253–271.
5. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, Herold CI, Marcom PK, George DJ and Garcia-Blanco MA (2011) Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9, 997–1007.
6. Arnoux V, Nassour M, L'Helgoualc'h, Hipskind RA and Savagner P (2008) Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 19, 4738–4749.
7. Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J and De Herreros AG (2000) The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2, 84–89.
8. Beerling E, Seinstra D, de Wit E, Kester L, van der Velden D, Maynard C, Schäfer R, van Diest P, Voest E, van Oudenaarden A et al. (2016) Plasticity between epithelial and mesenchymal states unlinks EMT from metastasis-enhancing stem cell capacity. Cell Rep 14, 2281–2288.
9. Beltran H, Prandi D, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BVSK, Varambally S et al. (2016) Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med 22, 298–305.
10. Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST et al. (2011) Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov 1, 487–495.
11. Benedito R, Roca C, Sörensen I, Adams S, Gossler A, Fruttiger M and Adams RH (2009) The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137, 1124–1135.
12. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE and Mackenzie IC (2011) Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res 71, 5317–5326.
13. Bittermann P, Chun B and Kurman R (1990) The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study. Am J Surg Pathol 14, 317–328.
14. Boareto M, Jolly MK, Ben-Jacob E and Onuchic JN (2015a) Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision. Proc Natl Acad Sci U S A 112, E3836–E3844.
15. Boareto M, Jolly MK, Goldman A, Pietila M, Mani SA, Sengupta S, Ben-Jacob E, Levine H and Onuchic JN (2016) Notch-Jagged signaling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface 13, 20151106.
16. Boareto M, Jolly MK, Lu M, Onuchic JN, Clementi C and Ben-Jacob E (2015b) Jagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype. Proc Natl Acad Sci U S A 112, E402–E409.
17. Bockhorn M, Jain RK and Munn LL (2007) Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol 8, 444–448.
18. Bolós V, Peinado H, Pérez-Moreno MA, Fraga MF, Esteller M, Cano A (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 116, 499–511.
19. Bonnomet A, Syne L, Brysse A, Feyereisen E, Thompson EW, Noël A, Foidart J-M, Birembaut P, Polette M and Gilles C (2012) A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene 31, 3741–3753.
20. Bouchard G, Therriault H, Bujold R, Saucier C and Paquettte B (2017) Induction of interleukin-1β by mouse mammary tumor irradiation promotes triple negative breast cancer cells invasion and metastasis development. Int J Radiat Biol 93, 507–516.
21. Brabletz T (2012) To differentiate or not — routes towards metastasis. Nat Rev Cancer 12, 425–436.
22. Bracken CP, Gregory PA, Kolesnikoff N, Bert AG, Wang J, Shannon MF and Goodall GJ (2008) A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 68, 7846–7854.
23. Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J et al. (2014) Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancer-host interface. J Pathol 234, 410–422.
24. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S and Brabletz T (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9, 582–589.
25. Cano A, Pérez-Moreno Ma, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2, 76–83.
26. Celià-Terrassa T, Meca-Cortés Ó, Mateo F, De Paz AM, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M et al. (2012) Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122, 1849–1868.
27. Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D'Alessio AC, Young RA and Weinberg RA (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61–74.
28. Chao YL, Shepard CR and Wells A (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9, 179.
29. Chao Y, Wu Q, Acquafondata M, Dhir R and Wells A (2012) Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron 5, 19–28.
30. Cheung KJ and Ewald AJ (2014) Illuminating breast cancer invasion: diverse roles for cell-cell interactions. Curr Opin Cell Biol 30, 99–111.
31. Cheung KJ and Ewald AJ (2016) A collective route to metastasis: seeding by tumor cell clusters. Science 352, 167–169.
32. Cheung KJ, Gabrielson E, Werb Z and Ewald AJ (2013) Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639–1651.
33. Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS et al. (2016) Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters. Proc Natl Acad Sci U S A 113, E854–E863.
34. Christiansen JJ and Rajasekaran AK (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66, 8319–8326.
35. Clark AG and Vignjevic DM (2015) Modes of cancer cell invasion and the role of the microenvironment. Curr Opin Cell Biol 36, 13–22.
36. Comaills V, Kabeche L, Morris R, Zou L, Daniel A, Yu M, Madden MW, Licausi JA, Boukhali M, Tajima K et al. (2016) Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition. Cell Rep 17, 2632–2647.
37. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI et al. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 106, 13820–13825.
38. De Chiara L and Crean J (2016) Emerging transcriptional mechanisms in the regulation of epithelial to mesenchymal transition and cellular plasticity in the kidney. J Clin Med 5, 6.
39. DeLong W, Grignon D, Eberwein P, Shum D and Wyatt J (1993) Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med 117, 636–640.
40. Dunning W (1963) Prostate cancer in the rat. Natl Cancer Inst Monogr 12, 351–369.
41. Fang JH, Zhou HC, Zhang C, Shang LR, Zhang L, Xu J, Zheng L, Yuan Y, Guo RP, Jia WH et al. (2015) A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology 62, 452–465.
42. Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong STC, Choi H, El Rayes T, Ryu S, Troeger J et al. (2015) Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature 527, 472–476.
43. Friedl P, Locker J, Sahai E and Segall JE (2012) Classifying collective cancer cell invasion. Nat Cell Biol 14, 777–783.
44. Futterman MA, García AJ and Zamir EA (2011) Evidence for partial epithelial-to-mesenchymal transition (pEMT) and recruitment of motile blastoderm edge cells during avian epiboly. Dev Dyn 240, 1502–1511.
45. Gordon-Weeks AN, Lim SY, Yuzhalin AE, Jones K, Markelc B, Kim KJ, Buzzelli JN, Fokas E, Cao Y, Smart S et al. (2017) Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice. Hepatology 65, 1920–1935.
46. Greenburg G and Hay ED (1982) Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95, 333–339.
47. Grigore A, Jolly MK, Jia D, Farach-Carson M and Levine H (2016) Tumor budding: the name is EMT. Partial EMT. J Clin Med 5, 51.
48. Grosse-Wilde A, Fouquier d’ Herouei A, McIntosh E, Ertaylan G, Skupin A, Kuestner RE, del Sol A, Walters K-A, Huang S (2015) Stemness of the hybrid epithelial/mesenchymal state in breast cancer and its association with poor survival. PLoS One 10, e0126522.
49. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, Sancho E, Dedhar S, De Herreros AGG and Baulida J (2002) Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 277, 39209–39216.
50. Hajra KM, David YSC and Fearon ER (2002) The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62, 1613–1618.
51. Hansel DE, Nakayama M, Luo J, Abukhdeir AM, Park BH, Bieberich CJ, Hicks JL, Nelson WG, Mostwin JL, Phil D et al. (2011) Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate. Prostate 69, 603–609.
52. Haraguchi S, Fukuda Y, Sguisaki Y and Yamanaka N (1999) Pulmonary carcinosarcoma: immunohistochemical and ultrastructural studies. Pathol Int 49, 903–908.
53. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC and Weinberg RA (2006) The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A 103, 18969–18974.
54. Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJC, Greystoke A, Zhou C, Morris K et al. (2012) Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 30, 525–532.
55. Huang D and Du X (2008) Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J Gastroenterol 14, 1823–1827.
56. Huang RY-J, Wong MK, Tan TZ, Kuay KT, Ng AHC, Chung VY, Chu Y-S, Matsumura N, Lai H-C, Lee YF et al. (2013) An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 4, e915.
57. Issacs J, Heston W, Weissman R and Coffey DS (1978) Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT. Cancer Res 38, 4353–4359.
58. Issacs J, Wake N, Coffey DS and Sandberg A (1982) Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res 42, 2353–2371.
59. Jain RK (2013) Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol 31, 2205–2218.
60. Jeevan DS, Cooper JB, Braun A, Murali RAJ and Jhanwar-Uniyal M (2016) Molecular pathways mediating metastases to the brain via epithelial-to-mesenchymal transition: genes, proteins, and functional analysis. Anticancer Res 36, 523–532.
61. Jia D, Jolly MK, Boareto M, Parsana P, Mooney SM, Pienta KJ, Levine H and Ben-Jacob E (2015) OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget 6, 15436–15448.
62. Johnen N, Francart M-E, Thelen N, Cloes M and Thiry M (2012) Evidence for a partial epithelial-mesenchymal transition in postnatal stages of rat auditory organ morphogenesis. Histochem Cell Biol 138, 477–488.
63. Jolly MK, Boareto M, Huang B, Jia D, Lu M, Ben-Jacob E, Onuchic JN and Levine H (2015a) Implications of the hybrid epithelial/mesenchymal phenotype in metastasis. Front Oncol 5, 155.
64. Jolly MK, Boareto M, Lu M, Onuchic JN, Clementi C and Ben-Jacob E (2015b) Operating principles of Notch-Delta-Jagged module of cell-cell communication. New J Phys 17, 55021.
65. Jolly MK, Huang B, Lu M, Mani SA, Levine H and Ben-Jacob E (2014) Towards elucidating the connection between epithelial − mesenchymal transitions and stemness. J R Soc Interface 11, 20140962.
66. Jolly MK, Tripathi SC, Jia D, Mooney SM, Celiktas M, Hanash SM, Mani SA, Pienta KJ, Ben-Jacob E and Levine H (2016) Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget 7, 27067–27084.
67. Ju JA, Godet I, Ye IC, Byun J, Jayatilaka H, Lee SJ, Xiang L, Samanta D, Lee MH, Wu P-H et al. (2017) Hypoxia selectively enhances integrin α5β1 receptor expression in breast cancer to promote metastasis. Mol Cancer Res 15, 723–734.
68. Jung H, Lee KP, Park SJ, Park JH, Jang YS, Choi SY, Jung JG, Jo K, Park DY, Yoon JH et al. (2008) TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene 27, 2635–2647.
69. Kalluri R and Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420–1428.
70. Kats-Ugurlu G, Roodnik I, de Weijert M, Tiemessen D, Maass C, Verrjip K, van der Laak J, de Waal R, Mulders P, Oosterwijk E et al. (2009) Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. J Pathol 219, 287–293.
71. Kleer CG, van Golen KL, Braun T and Merajver SD (2001) Persistent E-cadherin expression in inflammatory breast cancer. Mod Pathol 14, 458–464.
72. Klymkowsky MW and Savagner P (2009) Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol 174, 1588–1593.
73. Krebs AM, Mitschke J, Losada ML, Schmalhofer O, Boerries M, Busch H, Boettcher M, Mougiakakos D, Reichardt W, Bronsert P et al. (2017) The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol 19, 518–529.
74. Ku SY, Rosario S, Wang Y, Mu P, Seshadri M, Goodrich ZW, Goodrich MM, Labbé DP, Gomez EC, Wang J et al. (2017) Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance. Science 355, 78–83.
75. Kuriyama S, Theveneau E, Benedetto A, Parsons M, Tanaka M, Charras G, Kabla A and Mayor R (2014) In vivo collective cell migration requires an LPAR2-dependent increase in tissue fluidity. J Cell Biol 206, 113–127.
76. Lambert AW, Pattabiraman DR and Weinberg RA (2017) Emerging biological principles of metastasis. Cell 168, 670–691.
77. Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC and Farace F (2011) Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 105, 1338–1341.
78. Lee JM, Dedhar S, Kalluri R and Thompson EW (2006) The epithelial–mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172, 973–981.
79. Leroy P and Mostov KE (2007) Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. J Cell Sci 18, 1943–1952.
80. Li C, Hong T and Nie Q (2016) Quantifying the landscape and kinetic paths for epithelial-mesenchymal transition from a core circuit. Phys Chem Chem Phys 18, 17949–17956.
81. Li W and Kang Y (2016) Probing the fifty shades of EMT in metastasis. Trends Cancer 2, 65–66.
82. Li D, Masiero M, Banham AH and Harris AL (2014) The notch ligand JAGGED1 as a target for anti-tumor therapy. Front Oncol 4, 254.
83. Lu M, Jolly MK, Levine H, Onuchic JN and Ben-Jacob E (2013) MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A 110, 18144–18149.
84. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715.
85. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL and Weinberg RA (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 104, 10069–10074.
86. McCart Reed AE, Kutasovic JR, Vargas AC, Jayanthan J, Al-Murrani A, Reid LE, Chambers R, Da Silva L, Melville L, Evans E et al. (2016) An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas. J Pathol 238, 489–494.
87. McKeithen D, Graham T, Chung LWK and Odero-Marah V (2011) Snail transcriptional factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells. Prostate 70, 982–992.
88. Micalizzi DS, Farabaugh SM and Ford HL (2010) Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15, 117–134.
89. Mu P, Zhang Z, Benelli M, Karthaus WR, Hoover E, Chen C-C, Wongvipat J, Ku S-Y, Gao D, Cao Z et al. (2017) SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84–88.
90. Naber HPH, Drabsch Y, Snaar-Jagalska BE, ten Dijke P and van Laar T (2013) Snail and Slug, key regulators of TGF-b-induced EMT, are sufficient for the induction of single-cell invasion. Biochem Biophys Res Commun 435, 58–63.
91. Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, Hines WC, Yaswen P, Werb Z and Ewald AJ (2012) ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci U S A 109, E2595–E2604.
92. Nieto MA (2013) Epithelial plasticity: a common theme in embryonic and cancer cells. Science 342, 1234850.
93. Nieto MA, Huang RY, Jackson RA and Thiery JP (2016) EMT: 2016. Cell 166, 21–45.
94. Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A and Nieto MA (2012) Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709–724.
95. Oltean S, Febbo PG and Garcia-Blanco MA (2008) Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo. Clin Exp Metastasis 25, 611–619.
96. Oltean S, Sorg BS, Albrecht T, Bonano VI, Brazas RM, Dewhirst MW and Garcia-Blanco MA (2006) Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc Natl Acad Sci U S A 103, 14116–14121.
97. Ombrato L, Malanchi I (2014) The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog 19, 349–361.
98. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES and Weinberg RA (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68, 3645–3654.
99. Paniz Mondolfi AE, Jour G, Johnson M, Reidy J, Cason RC, Barkoh BA, Benaim G, Singh R and Luthra R (2013) Primary cutaneous carcinosarcoma: insights into its clonal origin and mutational pattern expression analysis through next-generation sequencing. Hum Pathol 44, 2853–2860.
100. Pattabiraman DR and Weinberg RA (2017) Targeting the epithelial-to-mesenchymal transition: the case for differentiation-based therapy. Cold Spring Harb Symp Quant Biol LXXXI, 30957. https://doi.org/10.1101/sqb.2016.81.030957.
101. Presnell S, Borchkert K, Glover W, Gregory C, Mohler J and Smith G (1998) Isolation and characterization of propagable cell lines (HUNC) from the androgen-sensitive Dunning R3327H rat prostatic adenocarcinoma. Carcinogenesis 19, 585–590.
102. Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE and Andrulis IL (2008) JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat 111, 439–448.
103. Revenu C and Gilmour D (2009) EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev 19, 338–342.
104. Rhim AD, Mirek ET, Aiello NM, Maitra A, Jennifer M, Mccallister F, Reichert M, Beatty GL, Anil K, Vonderheide RH et al. (2013) EMT and dissemination precede pancreatic tumor formation. Cell 148, 349–361.
105. Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, Condeelis JS and Jones JG (2009) Tumor microenvironment of metastasis in human breast carcinoma: A potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15, 2433–2441.
106. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M et al. (2016) Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget 8, 34205–34222.
107. Ruegg C, Monnier Y, Kuonen F and Imaizumi N (2011) Radiation-induced modifications of the tumor microenvironment promote metastasis. Bull Cancer 98, 47–57.
108. Ruscetti M, Quach B, Dadashian EL, Mulholland DJ and Hong W (2015) Tracking and functional characterization of epithelial-mesenchymal transition and mesenchymal tumor cells during prostate cancer metastasis. Cancer Res 75, 2749–2759.
109. Sampson VB, David JM, Puig I, Patil PU, de Herreros AG, Thomas GV and Rajasekaran AK (2014) Wilms’ tumor protein induces an epithelial-mesenchymal hybrid differentiation state in clear cell renal cell carcinoma. PLoS One 9, e102041.
110. Sarioglu AF, Aceto N, Kojic N, Donaldson MC, Zeinali M, Hamza B, Engstrom A, Zhu H, Sundaresan TK, Miyamoto DT et al. (2015) A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods 12, 685–691.
111. Saunders LR and McClay DR (2014) Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition. Development 141, 1503–1513.
112. Savagner P (2015) Epithelial-mesenchymal transitions: from cell plasticity to concept elasticity. Curr Top Dev Biol 112, 273–300.
113. Schaeffer D, Somarelli JA, Hanna G, Palmer GM and Garcia-Blanco MA (2014) Cellular migration and invasion uncoupled: increased migration is not an inexorable consequence of epithelial-to-mesenchymal transition. Mol Cell Biol 34, 3486–3499.
114. Schliekelman MJ, Taguchi A, Zhu J, Dai X, Rodriguez J, Celiktas M, Zhang Q, Chin A, Wong C, Wang H et al. (2015) Molecular portraits of epithelial, mesenchymal and hybrid states in lung adenocarcinoma and their relevance to survival. Cancer Res 75, 1789–1800.
115. Sethi N, Dai X, Winter CG and Kang Y (2011) Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 19, 192–205.
116. Shamir ER, Pappalardo E, Jorgens DM, Coutinho K, Tsai WT, Aziz K, Auer M, Tran PT, Bader JS and Ewald AJ (2014) Twist1-induced dissemination preserves epithelial identity and requires E-cadherin. J Cell Biol 204, 839–856.
117. Shaw TJ and Martin P (2016) Wound repair: a showcase for cell plasticity and migration. Curr Opin Cell Biol 42, 29–37.
118. Shen Y, Chen H, Zhang J, Chen Y, Wang M, Ma J, Hong L, Liu N, Fan Q, Lu X et al. (2015) Increased Notch signaling enhances radioresistance of malignant stromal cells induced by glioma stem/progenitor cells. PLoS One 10, e0142594.
119. Shen X and Kramer RH (2004) Adhesion-mediated squamous cell carcinoma survival through ligand-independent activation of epidermal growth factor receptor. Am J Pathol 165, 1315–1329.
120. Shen A, Zhang Y, Yang H, Xu R and Huang G (2011) Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma. J Surg Oncol 105, 830–834.
121. Siegel R, Miller K and Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67, 7–30.
122. Simões B, O'Brien C, Eyre R, Silva A and Yu L (2015) Anti-estrogen resistance in human breast tumors is driven by JAG1-NOTCH4-dependent cancer stem cell activity. Cell Rep 29, 1968–1977.
123. Smolev J, Heston W, Scott W and Coffey D (1977) Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. Cancer Treat Rep 61, 273–287.
124. Somarelli JA, Boss M-K, Epstein JI, Armstrong AJ and Garcia-Blanco MA (2015) Carcinosarcomas: tumors in transition? Histol Histopathol 30, 673–687.
125. Somarelli JA, Schaeffer D, Bosma R, Bonano VI, Sohn JW, Kemeny G, Ettyreddy A and Garcia-Blanco MA (2013) Fluorescence-based alternative splicing reporters for the study of epithelial plasticity in vivo. RNA 19, 116–127.
126. Somarelli JA, Schaeffer D, Marengo MS, Bepler T, Rouse D, Ware KE, Hish AJ, Zhao Y, Buckley AF, Epstein JI et al. (2016a) Distinct routes to metastasis: plasticity-dependent and plasticity-independent pathways. Oncogene 35, 4302–4311.
127. Somarelli JA, Shelter S, Jolly MK, Wang X, Bartholf Dewitt S, Hish AJ, Gilja S, Eward WC, Ware KE, Levine H et al. (2016b) Mesenchymal-epithelial transition in sarcomas is controlled by the combinatorial expression of miR-200s and GRHL2. Mol Cell Biol 36, 2503–2513.
128. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A et al. (2008) The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 68, 537–544.
129. Spremulli E and Dexter D (1983) Human tumor cell heterogeneity and metastasis. J Clin Oncol 1, 496–509.
130. Stankic M, Pavlovic S, Chin Y, Brogi E, Padua D, Norton L, Massagué J and Benezra R (2013) TGF-b-Id1 signaling opposes twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell Rep 5, 1228–1242.
131. Strauss R, Li Z-Y, Liu Y, Beyer I, Persson J, Sova P, Möller T, Pesonen S, Hemminki A, Hamerlik P et al. (2011) Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One 6, e16186.
132. Sun Y, Campisi J, Higano C, Beer TM, Porter P, Coleman I, True L and Nelson PS (2012) Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B. Nat Med 18, 1359–1368.
133. Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, Liu L, Du R, Xia L, He L et al. (2009) Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 75, 1278–1287.
134. Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ et al. (2014) Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res 20, 890–903.
135. Tennant T, Kim H, Sokoloff M and Rinker-Schaeffer C (2000) The Dunning model. Prostate 43, 295–302.
136. Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2, 442–454.
137. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM and Haley JD (2011) A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28, 137–155.
138. Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong WC, Kato M, Prevost-Blondel A, Thiery JP and Abastado JP (2011) Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biol 9, e1001162.
139. Tomlinson JS, Alpaugh ML and Barsky SH (2001) An intact overexpressed E-cadherin/α, β-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 61, 5231–5241.
140. Tsai JH, Donaher JL, Murphy DA, Chau S and Yang J (2012) Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725–736.
141. Tsai JH and Yang J (2013) Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27, 2192–2206.
142. Varma S, Cao Y, Tagne JB, Lakshminarayanan M, Li J, Friedman TB, Morell RJ, Warburton D, Kotton DN and Ramirez MI (2012) The transcription factors grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation. J Biol Chem 287, 37282–37295.
143. Vega S, Morales AV, Ocaña OH, Valdés F, Fabregat I and Nieto MA (2004) Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 18, 1131–1143.
144. Vesuna F, van Diest P, Chen JH and Raman V (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367, 235–241.
145. Walentin K, Hinze C, Werth M, Haase N, Varma S, Morell R, Aue A, Pötschke E, Warburton D, Qiu A et al. (2015) A Grhl2-dependent gene network controls trophoblast branching morphogenesis. Development 142, 1125–1136.
146. Westcott JM, Prechtl AM, Maine EA, Dang TT, Esparza MA, Sun H, Zhou Y, Xie Y and Pearson GW (2015) An epigenetically distinct breast cancer cell subpopulation promotes collective invasion. J Clin Invest 125, 1927–1943.
147. Wiles ET, Bell R, Thomas D, Beckerle M and Lessnick SL (2013) ZEB2 represses the epithelial phenotype and facilitates metastasis in ewing sarcoma. Genes Cancer 4, 486–500.
148. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927–939.
149. Ye Y, Tellez JD, Durazo M, Belcher M, Yearsley K and Barsky SH (2010) E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Anticancer Res 30, 3903–3910.
150. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC, Wells MN, Shah AM et al. (2013) Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339, 580–584.
151. Zadran S, Arumugam R, Herschman H, Phelps ME and Levine RD (2014) Surprisal analysis characterizes the free energy time course of cancer cells undergoing epithelial-to-mesenchymal transition. Proc Natl Acad Sci U S A 111, 13235–13240.
152. Zhang S, Chung W, Wu G, Egan SE and Xu K (2014) Tumor-suppressive activity of lunatic fringe in prostate through differential modulation of notch receptor activation. Neoplasia 16, 158–167.
153. Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu C-C, LeBleu VS and Kalluri R (2015) Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature 527, 525–530.